Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood
Study Identifier
M10-275
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18+ years
Protocol Summary
The primary purpose of this study is to compare the safety and efficacy of ABT-335
(investigational drug) coadministered with atorvastatin and ezetimibe to atorvastatin
coadministered with ezetimibe in subjects with abnormal lipid (fat) levels in the blood.
Study Locations
Location
Status
Location
Birmingham, Alabama, United States, 35209
Status
Not applicable
Location
Columbiana, Alabama, United States, 35051
Status
Not applicable
Location
Hueytown, Alabama, United States, 35023
Status
Not applicable
Location
Ozark, Alabama, United States, 36360
Status
Not applicable
Location
Tuscaloosa, Alabama, United States, 35406
Status
Not applicable
Location
Sierra Vista, Arizona, United States, 85635
Status
Not applicable
Showing {first} - {last} of {total} Results